Sleeping pills and sedatives: risks you should know

Updated Well Day Media Editorial Team
The short answerSleeping pills can help in the short term but carry significant risks. A meta-analysis of studies in adults 60 and older found that sleeping pills lengthened sleep by only about 25 minutes on average, while side effects such as memory problems, daytime drowsiness and falls were much more common. For every person helped, about two had side effects.

Key points

What the research shows

A meta-analysis of 24 randomized trials of sedative hypnotics (benzodiazepines and Z-drugs) in people aged 60 and older found that sleep quality improved and total sleep increased by an average of about 25 minutes. But adverse cognitive events were 4.8 times more common and psychomotor events, such as falls and accidents, 2.6 times more common. For every 13 people treated, one had improved sleep; for every 6 people treated, one had an adverse event (Glass et al., 2005).

What guidelines recommend

The American College of Physicians recommends CBT-I as the initial treatment for chronic insomnia and suggests medications only when CBT-I alone has not worked, after discussing benefits, harms and costs (Qaseem et al., 2016). The European guideline makes similar recommendations and advises against long-term use of benzodiazepines and Z-drugs (Riemann et al., 2017).

In practice

Frequently asked questions

Are over-the-counter sleep aids safer?

Not necessarily. Many contain diphenhydramine or doxylamine, which the American Geriatrics Society advises older adults to avoid because of confusion, constipation and fall risk.

What about "Z-drugs" like zolpidem?

They carry FDA boxed warnings about complex sleep behaviors such as sleepwalking and sleep driving, which can cause serious injuries.

Sources

  1. Glass et al. (2005). Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331(7526):1169. doi:10.1136/bmj.38623.768588.47
  2. Qaseem et al. (2016). Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine 165(2):125-133. doi:10.7326/M15-2175
  3. Riemann et al. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research 26(6):675-700. doi:10.1111/jsr.12594

Prepared according to our evidence methodology and the principles of lifestyle medicine. For education only; it does not replace advice from your doctor.

Keep reading

Related topics from other pillars

Risky Substances tools